Clinical Trial Update: The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function [Phase 3]

View source ↗

Summary

A Phase 3 trial explored the role of the Angiotensin Type I receptor in regulating human coronary vascular function and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Heart Failure
• Hypertension
• Myocardial Infarction

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Heart Failure, Congestive | Phase 3 | Status: COMPLETED